Copyright Reports & Markets. All rights reserved.

Global Cancer Hormone Therapy Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Cancer Hormone Therapy Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cancer Hormone Therapy Drugs by Type
    • 1.3.1 Overview: Global Cancer Hormone Therapy Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Cancer Hormone Therapy Drugs Consumption Value Market Share by Type in 2023
    • 1.3.3 Tamoxifen
    • 1.3.4 Aromatase Inhibitors
    • 1.3.5 Antiandrogens
    • 1.3.6 Androgen Synthesis Inhibitors
    • 1.3.7 Other
  • 1.4 Global Cancer Hormone Therapy Drugs Market by Application
    • 1.4.1 Overview: Global Cancer Hormone Therapy Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Breast Cancer
    • 1.4.3 Prostate Cancer
  • 1.5 Global Cancer Hormone Therapy Drugs Market Size & Forecast
  • 1.6 Global Cancer Hormone Therapy Drugs Market Size and Forecast by Region
    • 1.6.1 Global Cancer Hormone Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Cancer Hormone Therapy Drugs Market Size by Region, (2019-2030)
    • 1.6.3 North America Cancer Hormone Therapy Drugs Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Cancer Hormone Therapy Drugs Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Cancer Hormone Therapy Drugs Market Size and Prospect (2019-2030)
    • 1.6.6 South America Cancer Hormone Therapy Drugs Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Cancer Hormone Therapy Drugs Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Cancer Hormone Therapy Drugs Product and Solutions
    • 2.1.4 Roche Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Amgen
    • 2.2.1 Amgen Details
    • 2.2.2 Amgen Major Business
    • 2.2.3 Amgen Cancer Hormone Therapy Drugs Product and Solutions
    • 2.2.4 Amgen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Amgen Recent Developments and Future Plans
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Cancer Hormone Therapy Drugs Product and Solutions
    • 2.3.4 Pfizer Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Pfizer Recent Developments and Future Plans
  • 2.4 Teva
    • 2.4.1 Teva Details
    • 2.4.2 Teva Major Business
    • 2.4.3 Teva Cancer Hormone Therapy Drugs Product and Solutions
    • 2.4.4 Teva Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Teva Recent Developments and Future Plans
  • 2.5 Takeda
    • 2.5.1 Takeda Details
    • 2.5.2 Takeda Major Business
    • 2.5.3 Takeda Cancer Hormone Therapy Drugs Product and Solutions
    • 2.5.4 Takeda Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Takeda Recent Developments and Future Plans
  • 2.6 Samyang Biopharmaceuticals
    • 2.6.1 Samyang Biopharmaceuticals Details
    • 2.6.2 Samyang Biopharmaceuticals Major Business
    • 2.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Product and Solutions
    • 2.6.4 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Samyang Biopharmaceuticals Recent Developments and Future Plans
  • 2.7 Tolmar
    • 2.7.1 Tolmar Details
    • 2.7.2 Tolmar Major Business
    • 2.7.3 Tolmar Cancer Hormone Therapy Drugs Product and Solutions
    • 2.7.4 Tolmar Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Tolmar Recent Developments and Future Plans
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Cancer Hormone Therapy Drugs Product and Solutions
    • 2.8.4 AstraZeneca Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 AstraZeneca Recent Developments and Future Plans
  • 2.9 Novartis
    • 2.9.1 Novartis Details
    • 2.9.2 Novartis Major Business
    • 2.9.3 Novartis Cancer Hormone Therapy Drugs Product and Solutions
    • 2.9.4 Novartis Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Novartis Recent Developments and Future Plans
  • 2.10 Aspen
    • 2.10.1 Aspen Details
    • 2.10.2 Aspen Major Business
    • 2.10.3 Aspen Cancer Hormone Therapy Drugs Product and Solutions
    • 2.10.4 Aspen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Aspen Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cancer Hormone Therapy Drugs Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Cancer Hormone Therapy Drugs by Company Revenue
    • 3.2.2 Top 3 Cancer Hormone Therapy Drugs Players Market Share in 2023
    • 3.2.3 Top 6 Cancer Hormone Therapy Drugs Players Market Share in 2023
  • 3.3 Cancer Hormone Therapy Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Cancer Hormone Therapy Drugs Market: Region Footprint
    • 3.3.2 Cancer Hormone Therapy Drugs Market: Company Product Type Footprint
    • 3.3.3 Cancer Hormone Therapy Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cancer Hormone Therapy Drugs Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Cancer Hormone Therapy Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Cancer Hormone Therapy Drugs Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Cancer Hormone Therapy Drugs Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Cancer Hormone Therapy Drugs Consumption Value by Type (2019-2030)
  • 6.2 North America Cancer Hormone Therapy Drugs Consumption Value by Application (2019-2030)
  • 6.3 North America Cancer Hormone Therapy Drugs Market Size by Country
    • 6.3.1 North America Cancer Hormone Therapy Drugs Consumption Value by Country (2019-2030)
    • 6.3.2 United States Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Cancer Hormone Therapy Drugs Consumption Value by Type (2019-2030)
  • 7.2 Europe Cancer Hormone Therapy Drugs Consumption Value by Application (2019-2030)
  • 7.3 Europe Cancer Hormone Therapy Drugs Market Size by Country
    • 7.3.1 Europe Cancer Hormone Therapy Drugs Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 7.3.3 France Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cancer Hormone Therapy Drugs Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Cancer Hormone Therapy Drugs Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Cancer Hormone Therapy Drugs Consumption Value by Region (2019-2030)
    • 8.3.2 China Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 8.3.5 India Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Cancer Hormone Therapy Drugs Consumption Value by Type (2019-2030)
  • 9.2 South America Cancer Hormone Therapy Drugs Consumption Value by Application (2019-2030)
  • 9.3 South America Cancer Hormone Therapy Drugs Market Size by Country
    • 9.3.1 South America Cancer Hormone Therapy Drugs Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cancer Hormone Therapy Drugs Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Cancer Hormone Therapy Drugs Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Cancer Hormone Therapy Drugs Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Cancer Hormone Therapy Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Cancer Hormone Therapy Drugs Market Drivers
  • 11.2 Cancer Hormone Therapy Drugs Market Restraints
  • 11.3 Cancer Hormone Therapy Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cancer Hormone Therapy Drugs Industry Chain
  • 12.2 Cancer Hormone Therapy Drugs Upstream Analysis
  • 12.3 Cancer Hormone Therapy Drugs Midstream Analysis
  • 12.4 Cancer Hormone Therapy Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cancer Hormone Therapy Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.
    The Global Info Research report includes an overview of the development of the Cancer Hormone Therapy Drugs industry chain, the market status of Breast Cancer (Tamoxifen, Aromatase Inhibitors), Prostate Cancer (Tamoxifen, Aromatase Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Hormone Therapy Drugs.
    Regionally, the report analyzes the Cancer Hormone Therapy Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Hormone Therapy Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Cancer Hormone Therapy Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Hormone Therapy Drugs industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Tamoxifen, Aromatase Inhibitors).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Hormone Therapy Drugs market.
    Regional Analysis: The report involves examining the Cancer Hormone Therapy Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Hormone Therapy Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Cancer Hormone Therapy Drugs:
    Company Analysis: Report covers individual Cancer Hormone Therapy Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Hormone Therapy Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Breast Cancer, Prostate Cancer).
    Technology Analysis: Report covers specific technologies relevant to Cancer Hormone Therapy Drugs. It assesses the current state, advancements, and potential future developments in Cancer Hormone Therapy Drugs areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Hormone Therapy Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Cancer Hormone Therapy Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Tamoxifen
    Aromatase Inhibitors
    Antiandrogens
    Androgen Synthesis Inhibitors
    Other
    Market segment by Application
    Breast Cancer
    Prostate Cancer
    Market segment by players, this report covers
    Roche
    Amgen
    Pfizer
    Teva
    Takeda
    Samyang Biopharmaceuticals
    Tolmar
    AstraZeneca
    Novartis
    Aspen
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Cancer Hormone Therapy Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Cancer Hormone Therapy Drugs, with revenue, gross margin and global market share of Cancer Hormone Therapy Drugs from 2019 to 2024.
    Chapter 3, the Cancer Hormone Therapy Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cancer Hormone Therapy Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Hormone Therapy Drugs.
    Chapter 13, to describe Cancer Hormone Therapy Drugs research findings and conclusion.

    Buy now